These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Can we IMPROVE-CHF management by measuring natriuretic peptides? Greenberg B Circulation; 2007 Jun; 115(24):3045-7. PubMed ID: 17576881 [No Abstract] [Full Text] [Related]
28. Natriuretic peptides: putting the evidence into practice. Andrade A; Sharar H Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420 [TBL] [Abstract][Full Text] [Related]
29. Natriuretic peptides and the heart: current and future implications for clinical biochemistry. Penney MD Ann Clin Biochem; 2005 Nov; 42(Pt 6):432-40. PubMed ID: 16259793 [TBL] [Abstract][Full Text] [Related]
30. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure. Morello AM; Januzzi JL Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901 [TBL] [Abstract][Full Text] [Related]
31. Natriuretic peptide testing in primary care patients. Emdin M; Fontana M; Poletti R; Gabutti A; Mammini C; Rossi A; Pastormerlo LE; Masi L; Passino C; Clerico A Clin Chem Lab Med; 2008; 46(11):1533-42. PubMed ID: 18847366 [TBL] [Abstract][Full Text] [Related]
33. Role of the brain natriuretic peptide in heart failure management. Kalsmith BM Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363 [No Abstract] [Full Text] [Related]
34. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure]. Rutten JH; Boomsma F; Van den Meiracker AH Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722 [TBL] [Abstract][Full Text] [Related]
36. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
39. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. Clerico A; Passino C; Franzini M; Emdin M Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871 [TBL] [Abstract][Full Text] [Related]
40. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. Nishikimi T; Matsuoka H Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232833 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]